| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,832 |
12,101 |
$1.57M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,163 |
7,084 |
$1.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,268 |
3,104 |
$789K |
| X4011 |
State-specific procedure code |
5,377 |
4,525 |
$675K |
| 80053 |
Comprehensive metabolic panel |
14,370 |
11,607 |
$383K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,341 |
13,892 |
$367K |
| 81001 |
|
9,807 |
8,006 |
$290K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,916 |
2,998 |
$277K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,616 |
4,477 |
$242K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,112 |
6,502 |
$207K |
| 87400 |
|
4,384 |
3,829 |
$187K |
| 71045 |
Radiologic examination, chest; single view |
3,773 |
3,012 |
$159K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,654 |
1,992 |
$152K |
| 87430 |
|
1,170 |
1,113 |
$144K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,484 |
2,383 |
$139K |
| 36415 |
Collection of venous blood by venipuncture |
14,786 |
10,967 |
$139K |
| Y7506 |
|
771 |
495 |
$105K |
| 82550 |
|
4,513 |
3,453 |
$97K |
| 71046 |
Radiologic examination, chest; 2 views |
824 |
760 |
$76K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,262 |
1,113 |
$75K |
| 81025 |
|
1,791 |
1,512 |
$72K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,271 |
1,942 |
$68K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,271 |
1,032 |
$67K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,265 |
888 |
$63K |
| 84484 |
|
4,232 |
3,065 |
$63K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
502 |
388 |
$60K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
521 |
451 |
$51K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,379 |
1,075 |
$49K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
448 |
200 |
$43K |
| 86756 |
|
287 |
269 |
$41K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,835 |
1,784 |
$39K |
| 82553 |
|
1,440 |
1,167 |
$36K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,345 |
1,098 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,350 |
2,174 |
$34K |
| 86141 |
|
1,488 |
1,213 |
$30K |
| 83880 |
|
1,296 |
1,043 |
$29K |
| 87040 |
|
1,096 |
687 |
$27K |
| 80306 |
|
2,677 |
1,892 |
$26K |
| 83605 |
|
1,067 |
847 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
547 |
399 |
$21K |
| 87634 |
|
349 |
337 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,689 |
1,950 |
$12K |
| 83690 |
|
2,217 |
1,613 |
$11K |
| 80061 |
Lipid panel |
1,088 |
968 |
$10K |
| 84145 |
|
452 |
386 |
$10K |
| 85027 |
|
619 |
431 |
$9K |
| 85610 |
|
633 |
511 |
$8K |
| 83735 |
|
2,790 |
2,092 |
$8K |
| 85730 |
|
608 |
488 |
$8K |
| 82803 |
|
193 |
154 |
$8K |
| 80143 |
|
891 |
638 |
$7K |
| 80179 |
|
841 |
609 |
$7K |
| 71250 |
|
318 |
264 |
$7K |
| 85007 |
|
641 |
459 |
$7K |
| 82375 |
|
179 |
141 |
$7K |
| 80076 |
|
2,264 |
1,659 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
141 |
113 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
104 |
87 |
$6K |
| 87077 |
|
63 |
53 |
$4K |
| 82150 |
|
116 |
88 |
$4K |
| 84100 |
|
2,159 |
1,598 |
$4K |
| 36591 |
|
166 |
78 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
564 |
506 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
14 |
$4K |
| 87581 |
|
17 |
15 |
$3K |
| 87486 |
|
17 |
15 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
17 |
15 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
156 |
131 |
$3K |
| 87807 |
|
262 |
239 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
16 |
14 |
$3K |
| 87186 |
|
48 |
39 |
$3K |
| 86677 |
|
13 |
13 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
50 |
40 |
$1K |
| 82607 |
|
99 |
88 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
34 |
25 |
$1K |
| 87187 |
|
15 |
12 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
41 |
40 |
$1K |
| 84550 |
|
294 |
252 |
$987.25 |
| J3490 |
Unclassified drugs |
4,989 |
3,257 |
$915.12 |
| 82728 |
|
106 |
99 |
$641.25 |
| 83655 |
|
90 |
82 |
$588.60 |
| 83615 |
|
32 |
31 |
$430.43 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
143 |
134 |
$357.00 |
| 36600 |
|
15 |
13 |
$254.03 |
| 84439 |
|
19 |
14 |
$103.80 |
| 83540 |
|
14 |
12 |
$61.29 |
| 81003 |
|
41 |
37 |
$59.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,358 |
840 |
$0.00 |
| 80050 |
General health panel |
32 |
24 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
95 |
66 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
12 |
$0.00 |